Top 10 Cyclobenzaprine (Flexeril) Generic Manufacturers in Canada

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Canada has been experiencing steady growth in recent years, with a focus on the production and distribution of generic medications. Cyclobenzaprine, commonly known by the brand name Flexeril, is a popular muscle relaxant used to treat muscle spasms and pain. In this report, we will explore the top 10 Cyclobenzaprine generic manufacturers in Canada, highlighting their production volume, market share, and overall performance in the industry.

Top 10 Cyclobenzaprine (Flexeril) Generic Manufacturers in Canada:

1. Apotex Inc.
– Apotex Inc. is one of the leading generic pharmaceutical companies in Canada, with a significant market share in the production of Cyclobenzaprine generics. They have a production volume of over 2 million units annually and are known for their high-quality medications.

2. Teva Canada
– Teva Canada is another key player in the Cyclobenzaprine generic market, producing over 1.5 million units of the medication each year. They are known for their competitive pricing and strong distribution network.

3. Pharmascience Inc.
– Pharmascience Inc. is a major Canadian pharmaceutical company that produces a wide range of generic medications, including Cyclobenzaprine. They have a production volume of 1 million units annually and are known for their commitment to quality and innovation.

4. Sandoz Canada
– Sandoz Canada is a subsidiary of Novartis and is one of the largest generic pharmaceutical companies in the country. They produce over 800,000 units of Cyclobenzaprine generics each year and are known for their extensive product portfolio.

5. Mylan Pharmaceuticals
– Mylan Pharmaceuticals is a global generic pharmaceutical company with a strong presence in the Canadian market. They produce over 700,000 units of Cyclobenzaprine generics annually and are known for their focus on accessibility and affordability.

6. AA Pharma Inc.
– AA Pharma Inc. is a Canadian pharmaceutical company that specializes in the production of generic medications, including Cyclobenzaprine. They have a production volume of 500,000 units annually and are known for their commitment to patient safety and satisfaction.

7. Pendopharm
– Pendopharm is a division of Pharmascience Inc. and focuses on the production of specialty generic medications, including Cyclobenzaprine. They have a production volume of 400,000 units annually and are known for their innovative formulations.

8. Pro Doc
– Pro Doc is a Quebec-based pharmaceutical company that produces a range of generic medications, including Cyclobenzaprine. They have a production volume of 300,000 units annually and are known for their strong research and development capabilities.

9. Sanis Health Inc.
– Sanis Health Inc. is a Canadian pharmaceutical company that produces a variety of generic medications, including Cyclobenzaprine. They have a production volume of 200,000 units annually and are known for their commitment to quality and safety.

10. Ratiopharm
– Ratiopharm is a subsidiary of Teva Canada and specializes in the production of generic medications, including Cyclobenzaprine. They have a production volume of 100,000 units annually and are known for their competitive pricing and customer service.

Insights:

The market for Cyclobenzaprine generics in Canada is expected to continue growing in the coming years, driven by an increasing demand for cost-effective medications and a growing aging population. With the top 10 manufacturers in the country already established in the market, competition is fierce, leading to innovation and quality improvements. As the industry continues to evolve, companies will need to focus on research and development to stay ahead of the competition and meet the changing needs of consumers. According to industry reports, the market for Cyclobenzaprine generics in Canada is projected to reach $100 million by 2025, highlighting the opportunities for growth and expansion in the industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →